What is the market capitalization of ImageneBio, Inc.?

ImageneBio, Inc. (IMA) has a market capitalization of approximately 61,471,259 USD.

How many ETFs hold IMA?

IMA is held by 1 ETFs tracked on Investir en Bourse.

Where can I buy IMA in Canada?

IMA can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

IMA

ImageneBio, Inc.

ImageneBio, Inc. (IMA) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 61 million USD (micro-cap).

Details

Price5.45 USD

Market cap61.47 M USD

Payout ratio0.00%

ROE-86.16%

Debt / Equity1.96%

SectorHealthcare

Websiteinmagenebio.com

Updated a few minutes ago

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.